Successful Clinical Response in Pneumonia Therapy (SCRIPT)

Request Access

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

R. Grant, L. Morales-Nebreda, Nikolay S. Markov, et al.. (2020). Nature. Cited 597 times. https://doi.org/10.1038/s41586-020-03148-w

Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia

C. Pickens, C. Gao, M. Cuttica, et al.. (2021). American Journal of Respiratory and Critical Care Medicine. Cited 122 times. https://doi.org/10.1164/rccm.202106-1354OC

Distinctive features of severe SARS-CoV-2 pneumonia.

G. S. Budinger, A. Misharin, K. Ridge, et al.. (2021). The Journal of clinical investigation. Cited 60 times. https://doi.org/10.1172/JCI149412

Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19

C. Gao, Benjamin D. Singer, N. Markov, et al.. (2023). The Journal of Clinical Investigation. Cited 39 times. https://doi.org/10.1172/JCI170682

Prolonged exposure to lung-derived cytokines is associated with activation of microglia in patients with COVID-19

R. Grant, Taylor A Poor, L. Sichizya, et al.. (2024). JCI Insight. Cited 13 times. https://doi.org/10.1172/jci.insight.178859

Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia

N. Markov, Ziyou Ren, Karolina J. Senkow, et al.. (2024). Nature Immunology. Cited 5 times. https://doi.org/10.1038/s41590-024-01914-w
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747